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Factors that affect albumin concentration in dialysis patients commonly in chronic renal failure and is a cardiovascular
and their relationship to vascular disease. risk factor in this population [4].
Introduction. Hypoalbuminemia is a powerful risk factor for To understand the relationship between hypoalbumi-cardiovascular mortality in hemodialysis patients (HD). In-
nemia and increased morbidity and mortality in HD pa-flammation causes a decrease in albumin synthesis and an in-
tients requires the precise causes of hypoalbuminemiacrease in albumin fractional catabolic rate, providing two mech-
anisms for hypoalbuminemia. The inflammatory response in dialysis patients be identified. Albumin synthesis is con-
alters the endothelium and plasma protein composition in ways trolled in part by nutrition, especially protein intake [5].
that favor vascular injury. Plasma volume is expanded in HD However, malnutrition alone does not cause hypoalbumin-patients, providing another mechanism for hypoalbuminemia.
emia unless patients are near starvation [6, 7]. For example,Fibrinogen levels are an independent risk factor for cardiovas-
cular disease (CVD) in HD patients, and fibrinogen levels are patients with anorexia nervosa have essentially normal al-
increased in HD patients. Plasma volume expansion is also an bumin levels. Thus, hypoalbuminemia suggests additional
independent risk factor for CVD. processes, such as activation of the systemic inflammatory
Methods. Albumin synthesis was measured in 74 HD pa-
response [8] or albumin loss [9], may be present.tients as the disappearance of [125I] human albumin over six
Albumin is a negative acute-phase protein [10]. HDweeks. Fibrinogen was measured in plasma. Plasma fibrinogen
mass was the product of fibrinogen concentration and plasma patients with hypoalbuminemia have reduced albumin
volume. synthesis and increased levels of acute-phase proteins [11].
Results. Albumin synthesis correlated positively with plasma We evaluated the relationship between serum albuminvolume (P  0.001). Fibrinogen concentration and plasma fi-
concentration and cytokine, or acute-phase protein lev-brinogen mass both correlated positively with albumin synthe-
els, as well as normalized protein catabolic rate (nPCR),sis (P  0.001).
Conclusion. Albumin levels are reduced as part of the acute- cross-sectionally [12, 13] and longitudinally in HD pa-
phase response in HD. Plasma volume expansion also tends tients. Cross-sectionally, albumin levels correlated in-
to decrease albumin concentration, but elicits an increase in versely with markers of acute inflammation, including Cits rate of synthesis, which, in turn, is associated with increased
reactive protein (CRP), or cytokines that control thefibrinogen levels. Thus, both inflammation and plasma volume
acute-phase response, such as interleukin-6 (IL-6) [14].expansion factors that reduce albumin concentration and are
independent cardiovascular risk factors, independently in- Additionally, albumin concentration correlated inversely
crease fibrinogen levels. with nPCR, reflecting interaction between dietary pro-
tein and serum albumin levels [13]. Interestingly, while
CRP levels correlated closely with contemporaneous val-
Serum albumin concentration is maintained in a nar- ues for serum albumin [13, 15], CRP levels did not predict
row range in healthy subjects. Decreased albumin levels future serum albumin levels [15, 16]. In contrast, serum
predict mortality in all populations, and are powerful levels of more long-lived acute-phase proteins, such as
predictors of CVD and all-cause mortality in HD pa- ceruloplasmin or -1 acid glycoprotein, predicted future
tients [1, 2]. Factors determining albumin concentration serum albumin [16]. Ceruloplasmin and -1 acid glyco-
are its synthesis rate, fractional catabolic rate-FCR [3], protein levels correlated positively with albumin frac-
exogenous loss, redistribution into the interstitium, and tional catabolic rate (FCR) [17], suggesting that one way
changes in plasma volume. Volume expansion occurs in which inflammation decreases serum albumin is by in-
creasing its catabolic rate constant. Thus, the acute-phase
response is one factor that strongly controls albuminKey words: plasma volume, hemodialysis, albumin synthesis, fibrino-
gen, acute phase. levels both by decreasing albumin synthesis and increas-
ing its FCR. 2003 by the International Society of Nephrology
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Fig. 1. Relationship between albumin syn-
thesis rate, plasma volume, and plasma fi-
brinogen mass in 74 HD patients. (A, left
panel) Albumin synthesis rate was measured
as the turnover of [125I] albumin over 6 weeks.
(B, right panel). Fibrinogen mass was the
product of plasma volume, measured as dilu-
tion of [125I] albumin and average fibrinogen
concentration in plasma measured during the
6-week period of measurement. Fibrinogen
was measured nephelometrically. Data are
from [42].
Table 1. Characteristics of the calcium-regulatory proteins MGP and Ahsg/fetuin
MGP Ahsg/fetuin
Molecular weight 10 kD 62 kD
Serum levels 60–130 U/L 0.5–1.0 g/L
Synthesis Vascular smooth muscle cells, chondrocytes Hepatocytes
Phenotype of knockout mice Aortic media calcifications, cartilage calcifications, Diffuse metastatic soft-tissue and intra-arterial calcification,
lethal due to aortic rupture impaired survival
Properties Vitamin K-dependent -carboxylation, necessary Negative acute-phase reactant TGF- antgonist, inhibitor of
for activation insulin receptor tyrosine kinase activity
Abbreviations are: MGP, matrix Gla protein and Ahsg/fetuin, 2-Heremans Schmid glycoprotein.
CRP levels predict cardiovascular risk both in the non- We determined the relationship between albumin ho-
meostasis and fibrinogen levels in HD patients to gaindialysis population [18] and in HD patients [2]. While
acute phase protein levels may simply reflect vascular insight into the mechanisms responsible for the very high
levels of fibrinogen found. In the setting of external pro-inflammation, the acute-phase response alters both the
endothelium and plasma protein composition in ways tein loss such as that which occurs in nephrotic syndrome
[31, 32], or from transperitoneal albumin loss in perito-that would promote vascular injury. Endothelial reactiv-
ity is decreased [19] in part from increased utilization of neal dialysis patients [33], albumin synthesis is increased
probably in response to low oncotic pressure. Albuminnitric oxide by myeloperoxidase (MPO) [20]. Vascular
permeability is increased as are expression of specific synthesis is transcriptionally regulated in this regulatory
loop [34, 35]. In nephrotic syndrome, fibrinogen synthesisreceptors that bind leukocytes [21]. These release cyto-
kines locally, as well as MPO. Low-density lipoprotein and level is increased [35, 36]. In contrast to the acute-
phase response, external protein loss is associated with(LDL) is oxidized and high-density lipoprotein (HDL)
that would normally reduce it, becomes dysfunctional increased synthesis and transcription of genes encoding
both negative [37, 38] and positive acute-phase proteins,by the replacement of apo A-I with serum amyloid A,
an acute phase protein [22]. Lipoprotein (a) is a highly such as fibrinogen and albumin [37, 39]. This observation
suggests that the genes encoding both positive and nega-atherogenic lipoprotein whose level is usually genetically
controlled [23], but is increased in patients with renal tive acute-phase proteins may be regulated so that they
are expressed coordinately rather than reciprocally byfailure [24] and is associated with increased mortality in
HD [25]. Lp(a) is increased in conjunction with acute- conditions that tend to reduce plasma oncotic pressure.
Thus, two separate and unrelated processes, inflamma-phase proteins [26].
Fibrinogen is another acute-phase protein. Fibrinogen tion and loss of albumin from the body, each have the
potential to reduce albumin concentration and increaselevels are significantly greater ESRD patients compared
with healthy subjects, and are an independent cardiovas- fibrinogen synthesis.
Plasma volume expansion should cause dilution ofcular risk factor for ESRD patients [27, 28], for vascular
access failure [29], and for the general population [30]. plasma proteins and a reduction in serum levels. The
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